Re-Born in the USA: Who will Benefit from the Reshoring Trend?

Re-Born in the USA: Who will Benefit from the Reshoring Trend?

In recent years, the trend of deglobalisation and “reshoring”—bringing manufacturing production back home to the US—has gained momentum. This shift is accelerating due to the Biden administration’s investments, tax incentives, and a tougher stance on China’s technological ambitions. While offshore production sites face setbacks, the U.S. economy and various key industries stand to benefit.

Globalisation, once seen as an unstoppable force, has slowed since the early 2000s due to rising U.S. income inequality and shifting perceptions of offshore manufacturing. The COVID-19 pandemic exposed the fragility of global supply chains, leading to widespread shortages and logistical challenges. Factories shut down, postal services were overwhelmed, and even hospitals struggled to secure essential supplies. Governments and companies are now focused on strengthening domestic supply chains to mitigate these vulnerabilities.

Geopolitical developments, such as increased scrutiny of foreign investments and national security concerns, have further decelerated globalisation. Recent events, including the Russia-Ukraine conflict, and U.S.-China trade tensions, have highlighted the risks of global supply chains, driving a renewed focus on localising production.

As we delve deeper, we’ll uncover some of the key beneficiaries of this reshoring trend, exploring how these developments act as a powerful tailwind for future growth.

The Shift Away from Globalisation

Starting in the 1970s, the opening of developing markets, particularly China, to international trade and finance led to a strong movement toward the globalisation of production and supply chains. American manufacturers benefited from offshoring—outsourcing production to other countries—by cutting costs, improving efficiency, and accessing new markets.

However, globalisation also brought significant drawbacks. The U.S. economy suffered from the massive loss of manufacturing jobs, deterioration of domestic capabilities, and expanded trade and budget deficits. Offshoring companies became increasingly dependent on foreign suppliers and exposed to risks such as intellectual property theft, exchange rate fluctuations, political instability, and natural disasters.

More recently, several factors have spurred the drive toward improved supply chain resilience:

  • Increasing interdependence of global supply chains.
  • Vulnerability of lean supply chains to external shocks from the pandemic, tight labour markets, or shipping container shortages.
  • Rising geopolitical tensions among trading partners, heightening the risk that a single partner could disrupt the flow of needed supplies.

Geopolitical tensions, natural disasters, and economic uncertainties continue to threaten globalisation. As the U.S.-China clash over cutting-edge technology intensifies, the Biden administration has ramped up efforts to retain intellectual property and jobs domestically through economic support for reshoring companies and limiting Chinese access to U.S. technology.

Advantages of Reshoring

Reshoring offers numerous benefits for the U.S. economy, such as reducing unemployment, increasing the skilled workforce, fostering productive communities, and cutting trade deficits. For instance, 38% of new jobs created in 2022 were attributed to reshoring operations, with an additional 300,000 jobs created in 2023. However, the advantages of reshoring extend beyond macroeconomic impacts and significantly benefit companies that bring their operations back home.

By producing in the U.S., companies can cut costs that have risen dramatically in offshore production countries over the past decade or two. These include increasing wages abroad, higher transportation costs, stringent quality control measures, and the necessity of protecting intellectual property rights. Additionally, reshoring can lead to shorter delivery times, availability of skilled labour, and a reduced carbon footprint, all of which are becoming increasingly important in today’s market.

In summary, offshore production has become much less justified economically than a decade ago, while the risks of long and complex supply chains have become substantially more acute.

Government Support for Reshoring

Reshoring is a complex and costly process, requiring significant support from policymakers. The U.S. government has introduced several initiatives to aid businesses in navigating these challenges. The Infrastructure Investment and Jobs Act (IIJA), the Inflation Reduction Act (IRA), and the CHIPS Act are pivotal in supporting American businesses, providing over US$2 trillion in federal spending over the next decade. These initiatives aim to enhance U.S. economic competitiveness, innovation, and industrial productivity.

And, at the business level, it’s already working. According to a survey by Kearney, 96% of CEOs are evaluating reshoring, have decided to reshore, or have already reshored their operations, a significant increase from 78% in 2022. Additionally, mentions of “reshoring” in company earnings reports are rising faster than mentions of “Artificial Intelligence (AI),” highlighting the growing importance of this trend.

Key Beneficiaries of Reshoring

Many U.S. businesses across various industries are investing in reshoring their production and sourcing. Technology firms like Intel (NASDAQ: INTC), Texas Instruments (NASDAQ:TXN), and Taiwan Semiconductor (NYSE:TWN) are direct beneficiaries of the CHIPS Act, which provides grants to companies expanding semiconductor production in the U.S.

In November 2022, Panasonic (TYO:6752) began constructing a new lithium-ion battery manufacturing facility in Kansas, expected to create 4,000 jobs and represent the largest private investment in the state’s history. This facility is part of Panasonic’s strategy to expand its battery production capabilities in the U.S. The company already operates a joint battery plant with Tesla in Nevada and plans to build a third somewhere in the central U.S.

Additionally, late in 2023, Micron (NASDAQ:MU) announced plans to build a US$20 billion semiconductor chip factory in New York, which could eventually grow to a US$100 billion investment, creating 50,000 jobs. 

Broader Industrial Impact

The Inflation Reduction Act (IRA), focusing on clean energy technologies, energy efficiency, and reduced healthcare costs, is already boosting U.S. manufacturing. The IRA, along with the CHIPs Act and the Infrastructure Investment and Jobs Act, is expected to drive substantial infrastructure spending for years to come. This spending will benefit numerous companies across industrial, construction, and material sectors, where there is exponential growth required to address surging demands, as we discussed in Power Play: Investing In Energy For Innovation

The TAMIM Takeaway

As the U.S. continues to navigate geopolitical and economic challenges, reshoring will remain a critical strategy for sustainable growth and innovation. This trend is creating significant opportunities across various sectors, supported by government initiatives like the Infrastructure Investment and Jobs Act, the Inflation Reduction Act, and the Chips Act, which foster a favourable macro environment for companies poised to thrive.

For global investors, companies benefiting from reshoring, along with other secular tailwinds, present promising long-term prospects. These companies are positioned to capitalise on cost efficiencies, reduced supply chain risks, and robust policy support for innovation and growth.

TAMIM has just launched the new Global Tech and Innovation unit class which takes advantage of these reshoring trends. Please click here to see more information on this exciting new investment opportunity.

_____________________________________________________________________________________

Disclaimer: Texas Instruments (NASDAQ: TXN) is held in TAMIM Portfolios as at date of article publication. Holdings can change substantially at any given time.

Weekly Reading List – 4th of July

This week’s reading and viewing list covers The Magic of Compounding and Mark Zuckerberg on Creators, AI Studio, Neural Wristbands, Holographic Smart Glasses, Picasso & More. 

 

📚 The Roundup: Top Takeaways from Oaktree Conference 2024 (Howard Marks, Oaktree co-CEOs Robert O’Leary and Armen Panossian)

📚 The Petrodollar Is Dead, Long Live the Petrodollar (Javier Blas, Bloomberg)

📺 Mark Zuckerberg on Creators, AI Studio, Neural Wristbands, Holographic Smart Glasses, Picasso & More (Kallawy (YouTube)

📚 The Life Cycle of Market Champions (Bridgewater)

📚 Finding Great Leaders Early (Ian Cassel)

📚 Melinda French Gates: Here’s the best lesson I got from Charlie Munger (CNBC)

📚 The Magic of Compounding (The Rational Walk)

🎙️Bogumil Baranowski on Building Generational Wealth and Playing the Infinite Game of Investing (The One Percent Show)

Rebounding Electric Vehicle Share Prices: Tesla and Rivian

Rebounding Electric Vehicle Share Prices: Tesla and Rivian

Throughout market history, stocks, sectors, and thematic investments have experienced a swinging pendulum of sentiment, oscillating between overly pessimistic and overly optimistic extremes. As we’ve noted many times, successful investing requires second-level thinking—moving beyond the headlines and digging deeper to understand whether forecasts are exceedingly bearish or bullish.

One area recently bucking some overly negative sentiment is the electric vehicle (EV) sector. Investors should note several important statistics. The EV market continues to grow, even if growth rates fluctuate. For instance, EV sales in the U.S. jumped 60% last year, from 1 million in 2022 to 1.6 million in 2023. To put this in perspective, in 2016, only 200,000 EVs were sold in the U.S., which is eight times fewer than today’s annual sales.

It is true the internal combustion engine (ICE) vehicles still dominate, commanding around 75% of total U.S. vehicle sales. However, EV sales have continued to climb in 2024. The same is true across Australian and Europe – while the growth rate of EVs may not be as steep as it was in 2022 and 2023, overall the EV market continues to increase.

So why are the share prices of EV makers like Tesla (NASDAQ: TSLA) down so much (at the time of writing) this year? 

The issue isn’t growth—it’s expectations.

Tesla: Addressing Challenges and Showing Resilience

Shares of Tesla have been on a comeback trail recently. Tesla has faced numerous challenges this year, including slowing sales growth across the EV sector, distractions for CEO Elon Musk, and increased competition. These factors combined to push a negative narrative and sentiment towards the company. 

However, the company has shown resilience in the first six months of 2024. In June, Tesla shareholders approved a controversial pay package for Musk, lifting a significant weight off the sentiment and sparking renewed investor confidence.

Now, after reporting stronger-than-anticipated vehicle deliveries, the Tesla share price has surged again helping the company increase its market cap by over 40% in the past four weeks.

In the second quarter of CY24, Tesla delivered nearly 444,000 EVs, surpassing the consensus estimate of 439,000 units. Despite a 4.8% decline from the year-ago period, the figure rose 14.8% from the first quarter.

In more good news, Tesla marked a record 9.4 GWh (gigawatt hours) of energy storage products deployed in the second quarter. This more than doubled the previous record of 4.1 GWh reported in Q1 2024.

There’s been a surge in interest in energy storage products to smooth out power supply as renewable energy sources are installed for applications including growing data centre construction.

The rise in energy storage deployments favourably positions Tesla with yet another source of revenue for the company. Tesla prides itself on technology – software, energy storage, robotics, and the potential for self-driving vehicles. 

Tesla will continue to push the case that it is more than “just an EV car maker” when it provides an update on its self-driving technology on August 8.

Rivian: Securing a Lifeline Through Volkswagen Investment

EV start-up Rivian (NASDAQ: RIVN), despite developing a unique brand and increasing sales over the last two years, continues to face significant cash flow challenges. However, a lifeline emerged last week when global automaker Volkswagen (ETR: VOW3) agreed to invest up to US$5 billion in Rivian over the next two years.

This investment led to a surge in Rivian’s share price, although the stock remains down nearly 43% in 2024. Volkswagen’s investment will initially be US$1 billion in the form of a convertible note, converting to Rivian shares once regulatory approvals are received. Additionally, Volkswagen plans to invest another US$4 billion through a joint venture focused on developing next-generation EV architecture.

For Rivian, this substantial cash infusion will allow continued business scaling. Combined with its existing US$7.9 billion cash balance, this investment provides ample resources to ramp up production of lower-priced R2 SUV models and build out a US$5 billion manufacturing campus in Georgia, USA.

The partnership will also enable Volkswagen to access Rivian’s valuable zonal hardware design, critical for its next-generation EVs. Rivian’s ability to reduce vehicle costs and improve manufacturing processes will be bolstered by Volkswagen’s expertise, positioning Rivian to potentially achieve a positive gross margin by the Q4 2024 and setting long-term targets for profitability.

The TAMIM Takeaway

It is common to see leading players in particular sectors bounce back once it becomes clear that broader initial fears were overdone. Savvy investors should take note when historical multiples reach relevant lows and when narratives, rather than facts, drive share prices down. While second-level thinking does not guarantee success in investing, truth-seeking remains a crucial skill. The rebound of Tesla and Rivian highlights the importance of looking beyond immediate challenges to recognise long-term potential and strategic opportunities.

______________________________________________________________________________________________________

Disclaimer: Tesla (NASDAQ: TSLA) and Rivian (NASDAQ: RIVN) are held in TAMIM Portfolios as at date of article publication. Holdings can change substantially at any given time.

Is this Oversold Company A Potential Takeover Target?

Is this Oversold Company A Potential Takeover Target?

The recent price decline in this company has pushed its valuation to levels that we feel not only represent an attractive entry point for long-term investors but also potentially position it as an appealing takeover target.

Market inefficiencies often create these types of opportunities, while others may be driven by short-term fear, or as we discussed last week tax loss selling, we see this as a chance to acquire shares in a business that is currently trading at a significant discount to its intrinsic value.

 

The Company

Mcpherson’s Ltd (ASX: MCP) is an Australian consumer products company with a diverse portfolio of well-known brands.

Their product range spans health, wellness, beauty, and household categories with key brands including Lady Jane, Manicare, Swispers which are all category leaders in the beauty accessories segment. Dr. LeWinn’s, a skincare line featuring an Inner Beauty range with vegan collagen products, and A’kin, which offers botanical-based hair and skin care solutions. McPherson’s is focused on natural and wellness-oriented products, catering to consumer trends in these areas. Their multi-brand strategy and involvement in various consumer product categories provides a diversified business model, offering resilience over time in a more difficult trading environment.

McPherson’s is susceptible to consumer discretionary spending but we believe the health and beauty category is generally more defensive than other discretionary retailers operating within the same demographic of clientele.

Financial Performance

McPherson’s reported its H1 FY24 results in February which reflected a significant transformation in the company’s business model.

Despite an 8% decrease in revenue to $103.4 million, the company achieved a notable improvement in gross margin, increasing from 47.5% to 51.1%. This margin expansion was primarily driven by the strategic shift towards higher-margin core brands and a reduction in input costs. The focus on cost management and efficiency led to a net profit after tax (NPAT) of $1.6 million, a significant improvement on the NPAT of $0.1 million in 1H23.

The company’s net debt position improved significantly, with net debt excluding lease liabilities decreasing by $5.9 million to $4 million.

Cash generation was also strong with $9.1 million in operating cash flows before interest and tax to 31 December 2023. An impressive transformation from the operating cash outflow of $6 million in the previous corresponding period. McPherson’s declared a 2 cent dividend and if maintained equates to an attractive 10% dividend yield.

The company’s improved financial position and enhanced profitability metrics indicate a more resilient and focused business model, positioning it well for future growth.

Divestment of Multix

McPherson’s recently completed the sale of its ‘Multix’ brand and inventory to International Consolidated Business Group Pty Ltd for $19 million, subject to post-completion adjustments.

The divestment follows a strategic review announced in November 2023, aligning with McPherson’s focus on its core health, wellness, and beauty brands. As a result of the sale, the company expects to incur a one-off, non-cash asset write-down of $10-11 million in FY24 related to the ‘Multix’ brand and allocated goodwill, with pre-tax divestment costs estimated at $1.5 million. CEO Brett Charlton emphasised that this move strengthens the company’s balance sheet and reshapes the business for its future as a pure-play health, wellness, and beauty company. The sale is part of McPherson’s broader transformation plan, which includes reviewing its route to market for its remaining brand portfolio.

We believe that this cash could lead to either potential merger and acquisition opportunities or be returned to shareholders.

Chemist Warehouse Influence

The company established a strategic alliance with Chemist Warehouse in March 2022 whereby McPherson’s was appointed as Chemist Warehouse’s exclusive long-term distributor of a select portfolio of Chemist Warehouse-owned or controlled health and beauty brands outside of the Chemist Warehouse Network in Australia and New Zealand.

At the time of the announcement, the exclusive distribution rights will be for an initial term of five years commencing on 1 July 2022. McPherson’s will have three five-year options to extend the arrangements, subject to certain minimum performance thresholds on a brand-by-brand basis.

A key part of the alliance was the issue of shares to Chemist Warehouse. Chemist Warehouse remains a significant shareholder in the business, owning just under 10% of the company.

A Potential Target

Following the divestment of Multix we see significant value in McPherson’s and believe it could be a takeover target now that it becomes a pure play brand owner of health and beauty brands.

With forecast future sales of $160 million and earnings before interest and tax (EBIT) margins of 7-10% over time, that equates to potential Ebit of around $11 million on an underlying basis in FY25/26, which places the company at an attractive enterprise value to EBIT of around 3.5 times. This attractive valuation could encourage bidders to re-emerge following previous bids in 2021. Just over 3 years ago Arrotex Australia lodged a $1.60 non-binding, indicative proposal for the company, valuing the business at about $205 million. This bid followed on from a rival bid of $172 million from Geminder. The Arrotex bid ultimately collapsed following a four-week period of due diligence.

With a current market capitalisation of just under $60 million and an improving and focussed business model could we see an opportunistic return bid or perhaps a new interest?

The TAMIM Takeaway

The recent downturn in McPherson’s share price presents an intriguing opportunity for long-term investors and potential acquirers alike.

Despite a slight revenue drop in H1 FY24, the company’s strategic pivot has driven a notable improvement in the financial position of the business. McPherson’s divestment of the Multix brand, coupled with a strengthened balance sheet and its strategic alliance with Chemist Warehouse, enhances its focus on health, wellness, and beauty. With a compelling valuation, we believe McPherson’s is an attractive prospect.

The company’s transformation and current valuation make it an appealing takeover target amid rising merger and acquisition activity in the market.

_____________________________________________________________________________________________________

Disclaimer: Mcpherson’s Ltd (ASX: MCP) is held in TAMIM Portfolios as at date of article publication. Holdings can change substantially at any given time.

Will the Market Close the Gap on this Small Cap’s Valuation?

Will the Market Close the Gap on this Small Cap’s Valuation?

Often the market will present an opportunity where a high quality company’s true value isn’t reflected in its share price.

“In the short run, the market is a voting machine, but in the long run it is a weighing machine”.

A famous quote from Benjamin Graham. The quote highlights that in the short term, market prices fluctuate due to investor emotions and external events, creating potential mispricings. Over time, however, the true value of a company, based on its financial health and performance, becomes apparent. Thus, despite short-term volatility, long-term investors benefit by focusing on intrinsic value.

Another take from legendary investor Peter Lynch on market valuation:

“The stock market is filled with individuals who know the price of everything, but the value of nothing.”

Lynch considered that many market participants focus solely on stock prices without understanding the underlying business’s true worth. Individuals react to market trends and price movements rather than analysing a company’s fundamentals. Consequently, they miss the real value and potential of the investments, leading to misinformed decisions based on superficial metrics.

We’ve written about Close the Loop Group (ASX: CLG) here, we feel that this could be the best risk reward investment on the ASX.

The Business

As a refresher, Close the Loop Group (CLG) is a sustainability solutions company operating in the circular economy space.

It has two main divisions: Packaging (30% of revenue) and Resource Recovery (70%). The company specialises in manufacturing reusable packaging products, collecting and recycling printer cartridges, and repurposing electrical items such as notebooks, printers, gaming consoles etc for Original Equipment Manufacturers (OEM’s) like HP (NYSE: HPQ). CLG operates globally, with a presence in Australia, the US, Europe, and South Africa.

CLG has continued to make significant strides globally, particularly in the US market. Having acquired ISP Tek Services in 2023, CLG has strengthened its position in the electronics repurposing sector. This acquisition is seen as a key growth driver for the group, offering opportunities to expand work with major OEMs and other manufacturers in the future. CLG continues to explore new opportunities across the US, EU, and Middle East, with plans to establish a new IT refurbishment facility in Mexicali, Mexico, by October 2024.

The company has broadened its product range beyond its original focus on ink and toner cartridges. The company has developed innovative products such as TonerPlas® (an asphalt additive) and rFlex (a plastic resin made from post-consumer soft plastic). These new offerings have opened up additional revenue streams and market opportunities in the sustainable materials sector.

Why Close the Loop is Attractive?

There is an enormous opportunity in the global waste reduction market.

CLG has established a significant number of relationships with the largest OEMs for printer cartridge collection and recycling (300,000 global collection points). In the electronics space, CLG’s subsidiary ISP Tek is a valued partner for HP’s Renew business, which aims to minimise waste while generating commercial returns. Renew Solutions, established by HP in 2023, sells refurbished computers and printers through select partners. In April 2024, HP expanded its Certified Refurbished PC program to the US, Australia, the UK, the UAE, and other regions. ISP is one of a few certified partners and holds an exclusive three-year contract for North America.

This positions CLG to benefit from the increasing focus on sustainability and circular economy principles. For example, HP alone sells over 40 million notebooks pa whilst currently CLG only refurbishes less than 500k pa. We believe there’s a huge opportunity to expand their share and double the revenue from this division by expanding into 1, 2 and 3 year old products under warranty.

So far CLG has demonstrated impressive financial results and growth prospects whilst under promising and over delivering.

The company almost doubled revenue and net profit after tax (NPAT) in FY23. In addition, CLG at the 1H FY24 result has upgraded FY24 revenue to over $200 million, operating earnings of $44-46 million and NPATA of $26 million, reflecting continued growth. The continued synergies developed from recent acquisitions and further organic growth gives us confidence that further revenue growth and operating earnings expansion is achievable in the upcoming financial years.

Often companies that fall under the sustainability theme receive a ‘green premium’ and can often still be traded on potential while building a revenue base and operating at a loss.

CLG is a profitable business and generates healthy operating and net free cash flow. We expect this to continue in the coming years. While the company does have an expensive debt structure following its acquisitions we are hopeful it will be able to refinance this debt in the future on more favourable terms which could add $2 million to the profit line. From a net debt perspective, CLG net debt at the half was only $24 million or 0.5x Ebitda. We estimate a net cash position within 6-9 months as the company generates strong cashflows.

From a valuation standpoint we believe CLG is significantly undervalued.

On the forecast 2024 full year results the company will generate 4.9 cents in Cash EPS versus a share price of 32 cents. CLG trades on a PE multiple of 7x and EV/Ebitda of only 4x. On this multiple we believe the market does not fully appreciate CLG’s potential. Given the recent revenue growth and market potential we feel this is extremely low. Recent M&A in the sector was completed on 10x Ebitda (TES 2022).

Once the markets begin to appreciate CLG we feel there is an opportunity for multiple expansion and significant share price appreciation. Management’s aspirational target is $500 million of revenues in 2-3 years with current Ebitda margins of 20%+ this could potentially yield $100 million of Ebitda at that point. This will require good execution by the board and management, who combined, own 45% of the company and hence are completely aligned and incentivised to create shareholder value.

The TAMIM Takeaway

In our opinion CLG’s depressed valuation and a lack of understanding by investors about the business and opportunity represents the best risk reward investment currently on the ASX.

The company’s growth trajectory, impressive financial performance, and tailwinds of the circular economy sector makes it an attractive investment. As the market increasingly values sustainability and circular economy principles, CLG is well-placed to benefit from this trend. Should the strategic acquisitions continue to provide synergies we expect continued earnings growth providing even more value at the current share price. The company’s innovative products and expanding global footprint, underscore its potential for continued success.

Investors seeking a high-quality, undervalued company with significant growth potential should consider CLG a promising candidate.

_______________________________________________________________________________________________________________________

Disclaimer: Close the Loop Group (ASX: CLG) is held in TAMIM Portfolios as at date of article publication. Holdings can change substantially at any given time.